Hepatic clearance of drugs. III. Additional experimental evidence supporting the “wellstirred” model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liverin situ preparation
- 1 December 1977
- journal article
- research article
- Published by Springer Nature in Journal of Pharmacokinetics and Biopharmaceutics
- Vol. 5 (6) , 681-699
- https://doi.org/10.1007/bf01059690
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Hepatic clearance of drugs. II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparationJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearanceJournal of Pharmacokinetics and Biopharmaceutics, 1977
- Effects of route of administration and blood flow on hepatic drug elimination.1975
- Influence of congestive heart failure on blood levels of lidocaine and its active monodeethylated metaboliteClinical Pharmacology & Therapeutics, 1975
- Determination of Lidocaine in Blood and TissuesAnesthesiology, 1973
- The disposition of propranolol. 8. General implications of the effects of liver blood flow on elimination from the perfused rat liver.1973
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Influence of Route of Administration on Drug AvailabilityJournal of Pharmaceutical Sciences, 1972
- The effect of hepatic blood flow on the hepatic removal rate of oxyphenbutazone in the dog.1971
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951